Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 371-377, February 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirotnak, F. M.
Right arrow Articles by Donsbach, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirotnak, F. M.
Right arrow Articles by Donsbach, R. C.

Stereochemical Characteristics of the Folate-Antifolate Transport Mechanism in L1210 Leukemia Cells1

Francis M. Sirotnak and Ruth C. Donsbach

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The rate of influx, extent of concentrative uptake, and the rate of efflux (loss) by active transport in L1210 leukemia cells has been compared for the pteridine antifolates, aminopterin and methotrexate, eight related quinazoline analogs, and two pyrimidine derivatives. The data reveal a difference in the stereochemical specificity for influx and efflux. Influx is preferential in the order pteridine, quinazoline, and pyrimidine. Influx of aminopterin is more rapid than that of methotrexate. L-Glutamylquinazolines were taken up faster than L-aspartylquinazolines, but influx of a D-glutamylquinazoline was slower than the corresponding D-glutamylquinazoline was slower than the corresponding D-aspartyl derivative. Influx of the quinazolines was faster when there was a methyl- or chloro- substitution at position 5. Influx of the pyrimidines was also faster when a methyl group was at position 6. Michaelis constants (Km) for influx of the various analogs varied from 1.42 x 10-6 M to over 10-4 M. Individual Vmax values were essentially the same (1.87 to 2.22 nmoles/min/g dry weight). The relationship between the values for initial velocity of influx (v), the Km and Vmax obtained with each analog are in agreement with that predicted by the Michaelis-Menten equation and is consistent with the notion that differences in rates of influx are attributable to differences in the affinity of the carrier for the system. Efflux is preferential in the order pteridine, pyrimidine, and quinazoline. Efflux of aminopterin and methotrexate occurs at the same rate. Both aspartyl- and glutamylquinazolines efflux at about the same rate, but the D-aspartyl and D-glutamyl forms efflux more rapidly than the corresponding L forms. A methyl, and particularly a chloro, substitution at position 5 of the quinazoline reduces the rate of efflux. The extent of concentrative uptake observed for each analog directly reflects the relative magnitude at which the influx and efflux processes operate and may be the physiological parameter most relevant to therapeutic efficacy.

1 This work supported in part by Grant CA-08748 from the National Cancer Institute and Grant BC-108 from the American Cancer Society.

Received 6/20/73. Accepted 11/ 7/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.